Rein Therapeutics, Inc. Common Stock is a pharmaceutical preparations company trading on NASDAQ, led by CEO James Brian Windsor, with a market cap of $91.5M.
Based on Q1 2026 filing
Common questions about Rein Therapeutics, Inc. Common Stock
Rein Therapeutics, Inc. Common Stock (RNTX) has a market capitalization of $91.5M and trades on NASDAQ.
Rein Therapeutics, Inc. Common Stock has approximately 3 employees.